Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Fate Therapeutics Announces September Investor Events
-
Fate Therapeutics Announces September Investor Events
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fate Therapeutics (FATE) Prices 8.6M Share Offering at $17.50/Sh
-
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
-
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Fate Therapeutics (FATE) at Overweight
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
After-Hours Stock Movers 03/05: (GNCA) (TNTR) (ALOG) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Fate Therapeutics to Present at Upcoming Investor Conferences
-
Unusual 11 Mid-Day Movers 11/22: (SKLN) (CDNA) (BURL) Higher; (AMDA) (CHNR) (ASM) Lower
